Compound ID | 646
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Potent against RTI pathogens |
| Description: | Ebisu H, Abuki R, Takei M, et al. Novel oxazolidinones: antibacterial activities against respiratory pathogens and drug-resistant gram-positive bacteria. 46th-Intersci-Conf-Antimicrobial-Agents-Chemother 2006;212 |
| Institute where first reported: | Kyorin Pharmaceutical, Japan; Merck & Co, USA |
| Year first mentioned: | 2006 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | No development has been reported and has been in pre-clinical trials since 2006 indicating discontinuation |
| External links: | |
| Citation: |